Proteomics International launches diagnostic tests for major diseases

Proteomics International launches a commercial roadmap featuring a suite of four diagnostic tests aimed at kidney disease, cancer, and endometriosis. The tests will be available in Australia and the US, marking a significant shift from laboratory development to commercial application.

Read the full story at Sydney Morning Herald→